REENA MEHTA: Open Payments
NPI 1811335482 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 26 payments from 12 companies in 2025. Trend: 2023 $1,187 · 2024 $1,057 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $99 |
| GENZYME CORPORATION | 4 | $70 |
| PFIZER INC. | 4 | $67 |
| ABBVIE INC. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| TREACE MEDICAL CONCEPTS, INC. | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Gilead Sciences, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
Products named: TREMFYA, DUPIXENT, XIFAXAN, VOQUEZNA, RINVOQ, LAPIPLASTY SYSTEM 1, ENTYVIO, VELSIPITY.
Industry payments across NC — which companies pay providers there.
